Psoriasis Severity, Comorbidities, and Treatment Response Differ among Geographic Regions in the United States
Little is known about how psoriatic disease characteristics and treatment outcomes differ geographically in the United States. Our aim was to explore real-world, geographic variations in the use of biologic classes and outcomes within the Corrona Psoriasis Registry. Patient demographics and disease...
Main Authors: | Clinton W. Enos, Katie A. O’Connell, Ryan W. Harrison, Robert R. McLean, Blessing Dube, Abby S. Van Voorhees |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-06-01
|
Series: | JID Innovations |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667026721000254 |
Similar Items
-
Multiplicity of comorbidities in patients with severe psoriasis
by: N. V. Batkaeva, et al.
Published: (2018-04-01) -
Psoriasis and Comorbidities
by: Arzu Kılıç, et al.
Published: (2013-12-01) -
Management of moderate to severe psoriasis in patients with metabolic comorbidities
by: Paolo eGisondi, et al.
Published: (2015-01-01) -
Psoriasis Comorbidities in Childhood
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01) -
On the guestion of comorbidity in psoriasis
by: Bakulev A.L., et al.
Published: (2014-09-01)